ESCAPE pain trial –The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea: A triple-blinded, placebo-controlled, phase II, randomized clinical trial protocol

dc.contributor.authorVahid Nouri Kandany
dc.date.accessioned2026-01-19T20:31:40Z
dc.date.available2026-01-19T20:31:40Z
dc.date.issued2020-08-12
dc.description.abstractPrimary dysmenorrhea affects many women, being a major cause of absenteeism and reduced productivity at work and at school. Although non-steroidal anti-inflammatory drugs (NSAIDs) are a good treatment option, up to 18% of women show no response or present allergic reactions and adverse events. Curcumin has antispasmodic, antinociceptive, and both specific and nonspecific anti-inflammatory effects, with good tolerability and safety. To date, no previous trial involving curcumin and dysmenorrhea pain has been performed. Therefore, our main goal is to assess the efficacy of curcumin for pain relief among women with primary dysmenorrhea, along with determining curcumin’s adverse effects and tolerability profile.
dc.identifier.citationESCAPE pain trial - The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea: A triple blinded, placebo-controlled, phase II, randomized clinical trial protocol. (2020). Principles and Practice of Clinical Research, 6(2).
dc.identifier.urihttps://repositoriovip.uasd.edu.do/handle/123456789/1533
dc.language.isoen
dc.titleESCAPE pain trial –The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea: A triple-blinded, placebo-controlled, phase II, randomized clinical trial protocol
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea.pdf
Size:
724.99 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed to upon submission
Description: